Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-02-05

AUTHORS

Arthur P. DeMarzo

ABSTRACT

In November 2017, the American College of Cardiology and American Heart Association released new guidelines on hypertension that lowered the blood pressure (BP) definition of stage 1. Impedance cardiography (ICG) has shown that ventricular, vascular, and hemodynamic abnormalities are prevalent in adults over 40 years of age with at least 2 cardiovascular (CV) risk factors. This suggests that all stage 1 hypertension patients with multiple CV risk factors, over 40 years of age, have earlystage CV disease and should be treated. For many of these patients, ICG testing has shown low cardiac index with high systemic vascular resistance or vice versa. If only BP is measured, these significant extremes in hemodynamics would be unknown. With ICG data, drug selection and titration can be customized based on the abnormal underlying mechanisms to rapidly control BP while reducing adverse side effects and preventing progression of CV disease. More... »

PAGES

135-137

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40292-019-00304-w

DOI

http://dx.doi.org/10.1007/s40292-019-00304-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111910554

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30719630


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiography, Impedance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Decision-Making", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Dermed Diagnostics Inc, 2S 558 White Birch Lane, 60189, Wheaton, IL, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Dermed Diagnostics Inc, 2S 558 White Birch Lane, 60189, Wheaton, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DeMarzo", 
        "givenName": "Arthur P.", 
        "id": "sg:person.01321027317.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321027317.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40292-013-0009-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013048988", 
          "https://doi.org/10.1007/s40292-013-0009-0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-05", 
    "datePublishedReg": "2019-02-05", 
    "description": "In November 2017, the American College of Cardiology and American Heart Association released new guidelines on hypertension that lowered the blood pressure (BP) definition of stage 1. Impedance cardiography (ICG) has shown that ventricular, vascular, and hemodynamic abnormalities are prevalent in adults over 40\u00a0years of age with at least 2 cardiovascular (CV) risk factors. This suggests that all stage 1 hypertension patients with multiple CV risk factors, over 40 years of age, have earlystage CV disease and should be treated. For many of these patients, ICG testing has shown low cardiac index with high systemic vascular resistance or vice versa. If only BP is measured, these significant extremes in hemodynamics would be unknown. With ICG data, drug selection and titration can be customized based on the abnormal underlying mechanisms to rapidly control BP while reducing adverse side effects and preventing progression of CV disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40292-019-00304-w", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105561", 
        "issn": [
          "1120-9879", 
          "1179-1985"
        ], 
        "name": "High Blood Pressure & Cardiovascular Prevention", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "cardiovascular risk factors", 
      "years of age", 
      "risk factors", 
      "CV disease", 
      "multiple CV risk factors", 
      "multiple cardiovascular risk factors", 
      "higher systemic vascular resistance", 
      "impedance cardiography", 
      "blood pressure definition", 
      "CV risk factors", 
      "stage 1 hypertension", 
      "low cardiac index", 
      "systemic vascular resistance", 
      "American Heart Association", 
      "adverse side effects", 
      "ICG testing", 
      "cardiac index", 
      "vascular resistance", 
      "hemodynamic abnormalities", 
      "hypertension patients", 
      "Heart Association", 
      "cardiovascular disease", 
      "American College", 
      "side effects", 
      "drug selection", 
      "ICG data", 
      "disease", 
      "hypertension", 
      "new guidelines", 
      "underlying mechanism", 
      "patients", 
      "only BP", 
      "stage 1", 
      "age", 
      "hemodynamics", 
      "years", 
      "factors", 
      "abnormalities", 
      "cardiology", 
      "cardiography", 
      "progression", 
      "significant extremes", 
      "adults", 
      "association", 
      "guidelines", 
      "index", 
      "testing", 
      "College", 
      "BP", 
      "effect", 
      "resistance", 
      "mechanism", 
      "data", 
      "titration", 
      "definition", 
      "vice", 
      "selection", 
      "extremes", 
      "pressure (BP) definition", 
      "earlystage CV disease", 
      "abnormal underlying mechanisms"
    ], 
    "name": "Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension", 
    "pagination": "135-137", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111910554"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40292-019-00304-w"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30719630"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40292-019-00304-w", 
      "https://app.dimensions.ai/details/publication/pub.1111910554"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_824.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40292-019-00304-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40292-019-00304-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40292-019-00304-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40292-019-00304-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40292-019-00304-w'


 

This table displays all metadata directly associated to this object as RDF triples.

179 TRIPLES      22 PREDICATES      101 URIs      92 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40292-019-00304-w schema:about N1786e3d3bd544899a40455da6c016d4e
2 N2362bb38be274a6bacdca6ab53a2d718
3 N2d9dab0198c54d9ba5c76ec7cab3f6fa
4 N2f020e651bba4c45ae69afd645241c5a
5 N36763f7702b244a8aa844dbcc0d99428
6 N4382829fa1104d0ca85f8547eb514867
7 N54765436e6c04d80bb1613f52cf21f0d
8 N65608fd4cd794c00bc54218a83a3b063
9 Nb764934ebc6d4c2a96ce0ab048ccda1c
10 Nc6b05ab68b034b4a8356d6e3d5e0fe06
11 Nc740581d863b4d798b053854692792ce
12 Nd1c6a6994455454fae5c72e9793e1cdf
13 Nf1898d86508a4a158eb8c4ee91d29be4
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author N0157e9beba0c47c3a19a37280c5bec2b
17 schema:citation sg:pub.10.1007/s40292-013-0009-0
18 schema:datePublished 2019-02-05
19 schema:datePublishedReg 2019-02-05
20 schema:description In November 2017, the American College of Cardiology and American Heart Association released new guidelines on hypertension that lowered the blood pressure (BP) definition of stage 1. Impedance cardiography (ICG) has shown that ventricular, vascular, and hemodynamic abnormalities are prevalent in adults over 40 years of age with at least 2 cardiovascular (CV) risk factors. This suggests that all stage 1 hypertension patients with multiple CV risk factors, over 40 years of age, have earlystage CV disease and should be treated. For many of these patients, ICG testing has shown low cardiac index with high systemic vascular resistance or vice versa. If only BP is measured, these significant extremes in hemodynamics would be unknown. With ICG data, drug selection and titration can be customized based on the abnormal underlying mechanisms to rapidly control BP while reducing adverse side effects and preventing progression of CV disease.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N0f047849cb2143179e6e365a5084fdc9
25 N3beede84e43f4d88941c017294fe7cb5
26 sg:journal.1105561
27 schema:keywords American College
28 American Heart Association
29 BP
30 CV disease
31 CV risk factors
32 College
33 Heart Association
34 ICG data
35 ICG testing
36 abnormal underlying mechanisms
37 abnormalities
38 adults
39 adverse side effects
40 age
41 association
42 blood pressure definition
43 cardiac index
44 cardiography
45 cardiology
46 cardiovascular disease
47 cardiovascular risk factors
48 data
49 definition
50 disease
51 drug selection
52 earlystage CV disease
53 effect
54 extremes
55 factors
56 guidelines
57 hemodynamic abnormalities
58 hemodynamics
59 higher systemic vascular resistance
60 hypertension
61 hypertension patients
62 impedance cardiography
63 index
64 low cardiac index
65 mechanism
66 multiple CV risk factors
67 multiple cardiovascular risk factors
68 new guidelines
69 only BP
70 patients
71 pressure (BP) definition
72 progression
73 resistance
74 risk factors
75 selection
76 side effects
77 significant extremes
78 stage 1
79 stage 1 hypertension
80 systemic vascular resistance
81 testing
82 titration
83 underlying mechanism
84 vascular resistance
85 vice
86 years
87 years of age
88 schema:name Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension
89 schema:pagination 135-137
90 schema:productId N592747110fc44f1f87daf4b9c160aec7
91 N845e06fb3fef42eaacff9c822e03e434
92 Nd31ccf2cb02d4e059aa554c096457629
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111910554
94 https://doi.org/10.1007/s40292-019-00304-w
95 schema:sdDatePublished 2021-12-01T19:46
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher N9ddd5f6b964141a9a88a06185ee734f3
98 schema:url https://doi.org/10.1007/s40292-019-00304-w
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N0157e9beba0c47c3a19a37280c5bec2b rdf:first sg:person.01321027317.01
103 rdf:rest rdf:nil
104 N0f047849cb2143179e6e365a5084fdc9 schema:issueNumber 2
105 rdf:type schema:PublicationIssue
106 N1786e3d3bd544899a40455da6c016d4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Disease Progression
108 rdf:type schema:DefinedTerm
109 N2362bb38be274a6bacdca6ab53a2d718 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Humans
111 rdf:type schema:DefinedTerm
112 N2d9dab0198c54d9ba5c76ec7cab3f6fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Clinical Decision-Making
114 rdf:type schema:DefinedTerm
115 N2f020e651bba4c45ae69afd645241c5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Adult
117 rdf:type schema:DefinedTerm
118 N36763f7702b244a8aa844dbcc0d99428 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Male
120 rdf:type schema:DefinedTerm
121 N3beede84e43f4d88941c017294fe7cb5 schema:volumeNumber 26
122 rdf:type schema:PublicationVolume
123 N4382829fa1104d0ca85f8547eb514867 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Cardiography, Impedance
125 rdf:type schema:DefinedTerm
126 N54765436e6c04d80bb1613f52cf21f0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Severity of Illness Index
128 rdf:type schema:DefinedTerm
129 N592747110fc44f1f87daf4b9c160aec7 schema:name dimensions_id
130 schema:value pub.1111910554
131 rdf:type schema:PropertyValue
132 N65608fd4cd794c00bc54218a83a3b063 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Female
134 rdf:type schema:DefinedTerm
135 N845e06fb3fef42eaacff9c822e03e434 schema:name doi
136 schema:value 10.1007/s40292-019-00304-w
137 rdf:type schema:PropertyValue
138 N9ddd5f6b964141a9a88a06185ee734f3 schema:name Springer Nature - SN SciGraph project
139 rdf:type schema:Organization
140 Nb764934ebc6d4c2a96ce0ab048ccda1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Antihypertensive Agents
142 rdf:type schema:DefinedTerm
143 Nc6b05ab68b034b4a8356d6e3d5e0fe06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Treatment Outcome
145 rdf:type schema:DefinedTerm
146 Nc740581d863b4d798b053854692792ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Blood Pressure
148 rdf:type schema:DefinedTerm
149 Nd1c6a6994455454fae5c72e9793e1cdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Risk Factors
151 rdf:type schema:DefinedTerm
152 Nd31ccf2cb02d4e059aa554c096457629 schema:name pubmed_id
153 schema:value 30719630
154 rdf:type schema:PropertyValue
155 Nf1898d86508a4a158eb8c4ee91d29be4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Hypertension
157 rdf:type schema:DefinedTerm
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
162 schema:name Cardiorespiratory Medicine and Haematology
163 rdf:type schema:DefinedTerm
164 sg:journal.1105561 schema:issn 1120-9879
165 1179-1985
166 schema:name High Blood Pressure & Cardiovascular Prevention
167 schema:publisher Springer Nature
168 rdf:type schema:Periodical
169 sg:person.01321027317.01 schema:affiliation grid-institutes:None
170 schema:familyName DeMarzo
171 schema:givenName Arthur P.
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321027317.01
173 rdf:type schema:Person
174 sg:pub.10.1007/s40292-013-0009-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013048988
175 https://doi.org/10.1007/s40292-013-0009-0
176 rdf:type schema:CreativeWork
177 grid-institutes:None schema:alternateName Dermed Diagnostics Inc, 2S 558 White Birch Lane, 60189, Wheaton, IL, USA
178 schema:name Dermed Diagnostics Inc, 2S 558 White Birch Lane, 60189, Wheaton, IL, USA
179 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...